---
title: "Settling the paclitaxel versus sirolimus DCB debate"
date: "2024-02-27T16:43:50.000Z"
publishedDate: "27 février 2024"
summary: "Bernardo Cortese (Fondazione Ricerca e Innovazione Cardiovascolare, Lodi, Italy and DCB Academy) has been among the leaders in research on the use of drug-coated balloons (DCBs) in percutaneous coronary intervention (PCI) across Europe. As the approach continues to gain ground among physicians, new devices using novel coatings such as sirolimus as an alternative to the [&#8230;] The post Settling the paclitaxel versus sirolimus DCB debate appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/settling-the-paclitaxel-versus-sirolimus-dcb-debate/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-02-27-settling-the-paclitaxel-versus-sirolimus-dcb-debate"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/02/B-Cortese.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/settling-the-paclitaxel-versus-sirolimus-dcb-debate/"
---

![Settling the paclitaxel versus sirolimus DCB debate](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/02/B-Cortese.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/settling-the-paclitaxel-versus-sirolimus-dcb-debate/*

## L’essentiel

Bernardo Cortese (Fondazione Ricerca e Innovazione Cardiovascolare, Lodi, Italy and DCB Academy) has been among the leaders in research on the use of drug-coated balloons (DCBs) in percutaneous coronary intervention (PCI) across Europe. As the approach continues to gain ground among physicians, new devices using novel coatings such as sirolimus as an alternative to the [&#8230;] The post Settling the paclitaxel versus sirolimus DCB debate appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/settling-the-paclitaxel-versus-sirolimus-dcb-debate/
